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Background of Study 
Introduction 
Nitric oxide, NO, is a molecule with great versatility and 
importance. Made up of only a single atom of nitrogen and a single 
atom of oxygen, nitric oxide is perhaps one of the smallest 
paramagnetic molecules found in nature. The functions of NO in the 
body are not all known, but this molecule definitely plays a 
variety of roles. It is involved in the regulation of blood 
pressure, and it sometimes acts as a messenger for cells as well as 
a killer of them. It also is important in the defense of the body 
against foreign invaders. The significance of chemistry to nitric 
oxide's effects in the body are nowhere more aptly demonstrated 
than by the British chemist Sir Humphry Davy (Lancaster 250). 
Davy, who discovered the notorious laughing gas (nitrous 
oxide, N20), nearly died when he inhaled a small amount of nitric 
oxide. Although structurally related, these two molecules have two 
very different physiological effects. Made up of only fifteen 
electrons, nitric oxide contains one unpaired electron, which 
contributes to a property called paramagnetism. Since electrons 
tend to pair, molecules with unpaired electrons are very rare 
because they are so reactive. Nitric oxide tends to react rapidly 
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with other atoms or molecules with unpaired electrons. Among the 
molecules commonly present in cells, the most significant 
paramagnetic species are molecular oxygen (02), superoxide (02)" and 
various complexes of iron, copper, and manganese. Nitric oxide's 
reactions with molecular oxygen and metalloproteins dominate its 
chemistry and therefore its molecular actions in the cell. 
Statement of Problem 
Nitric oxide has many different functions in the human body. 
Many of these functions are Joeneficial, but some can be deadly. 
By finding out how nitric oxide binds to different enzymes and 
heme groups, one is able to get a better understanding of why 
it functions as it does in the human body. This could also 
provide scientists with information as to how to develop drugs that 
would turn the production of NO on and off. 
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Rationale for the Study 
The research on nitric oxide is relatively new. There are 
still many things that are unknown about this versatile molecule. 
Therefore, research on this particular molecule is of utmost 
importance when compared to another molecule such as 02 which has 
been researched thoroughly. Information from this research could 
contribute to a better understanding of the function of nitric 
oxide. 
Purpose of the Study 
The research in this study was performed following 
procedures from previous work done by various researchers. The 
purpose of this research is to provide new data that will help to 
explain the behavior of nitric oxide. This is achieved by making 
a porphyrin complex of NO that has never been made. This research 
focuses on the synthesis of six coordinate nitrosyl complexes as 
potential models for the study of the binding of NO to heme groups. 
By gathering data on how NO binds in the newly made compound, one 
can determine its ability to bind to porphyrins. The preparation 
of the compound was examined by the use of infrared and ultraviolet 
spectroscopy. All infrared spectra were taken on a BIO-RAD model 7 
FT-IR instrument using either KBr or solution technigues. UV-vis 
spectra were obtained on a Hewlett-Packard photodiode array 
instrument in a lab at the University of Oklahoma. 
Assumptions 
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There is only one assumption made about this experiment. This 
is that the procedures followed, based on the previous work done by 
various researchers, would also work in forming the new porphyrin 
compound. 
Limitations 
There are some limitations involved in this research. One is 
that small quantities of the starting porphyrin material were used; 
therefore, if the reaction has a small yield there would be little 
if any product remaining to characterize by spectural analysis. 
Also a glove bag had to be used to transfer materials under a 
nitrogen atmosphere. During this process it is easy to lose some of 
the product and therefore reduce the size of the compound that can 
be synthesized. 
Outline of Thesis 
The remainder of the thesis is composed of four chapters. 
Chapter II is the Review of Literature section, Chapter III is the 
Methodology section, Chapter IV is the Presentation of Findings 
section, and Chapter V is the Summary and Conclusion section. 
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Chapter II 
Review of Literature 
Just a decade ago nitric oxide (NO) was known as just another 
toxic molecule. Destroyer of ozone, suspected carcinogen, and 
precursor of acid rain were among a few of its effects (Culotta 
1862). Recently scientists have discovered that nitric oxide in 
small controlled quantities in the body can be quite beneficial. 
Nitric oxide has been found to occur naturally in at least a 
dozen cell types in various parts of the body. NO is produced by 
the enzyme nitric oxide synthase (Bredt and Snyder 684; Moncada 
2168; Mayer 682a, 217b; Knowles 5160). This enzyme requires a 
specific nitrogen atom from the amino acid arginine to synthesize 
nitric oxide. The oxygen atom, on the other hand, is derived from 
molecular oxygen. This reaction also requires an electron donor; 
in this case nicotinamide adenine dinucleotide phosphate (NADPH) 
and the cofactor tetrahydrobiopterin (HYBPT) are used. During the 
synthesis of nitric oxide, the removal of nitrogen from arginine 
produces the amino acid citrulline. Through experimental data 
collected from various cell types, it has been concluded that two 
forms of nitric oxide synthase exist (Moncada 123a). One form is 
found in the cells of the brain and in the wall of blood vessels. 
This is known as a constitutive enzyme because it is present at all 
times. This enzyme is activated by the regulatory protein, 
calmodulin, which itself is activated by an influx of calcium ions 
into the cell. The presence of the other form of nitric oxide 
6 
synthase is inducible. It is found within the immune-system cells 
called macrophages. The cell makes the enzyme only when it 
receives a specific signal. The inducible form of nitric oxide 
synthase can produce more nitric oxide than the constitutive form. 
This factor is a key to their differing roles in the body. To 
date, nitric oxide has been found in the brain, arteries, immune 
system, liver, pancreas, the gastrointestinal tract, peripheral 
nerves, lungs, uterus, and penis. This presence indicates that 
nitric oxide has many different functions within the human body. 
Many recent discoveries have greatly increased the interest in 
nitric oxide. Some researchers have found that nitric oxide lowers 
blood pressure (Ignarro 66 and Koshland 1861). This is 
accomplished by acetylcholine actions on endothelial cells. 
Acetylcholine activates receptors within the endothelial cell, 
which then in turn releases nitric oxide. The nitric oxide then 
diffuses into the overlying smooth muscle cells and induces them to 
relax, dilating the blood vessel and lowering blood pressure. 
Another significant finding is nitric oxide's ability to work 
as a defensive weapon against foreign reagents. Nitric oxide, when 
released by murine macrophage and other cells after immunological 
activation, acts as a cytotoxic molecule for invading intracellular 
microorganisms and tumor cells (Marietta 8708; Hibbs 90b; Stuehr 
1015; Moncada 135a). NO is also able to react with oxygen to 
ultimately produce the hydroxyl radical OH and nitrogen dioxide, 
which are known as potent cellular assassins. The laboratories of 
Hibbs and Jean-Claude Drapier of the Curie Institute of Paris found 
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that cells killed by macrophages lose the function of certain iron-
bearing enzymes (Lancaster 252 and Hibbs, J.B. 718a, 91b, 215c). 
This loss is due to the presence of nitric oxide, released by 
macrophages, which causes damage to cells by binding to certain 
enzymes involved in cellular respiration, thus preventing the cell 
from working and eventually "starving" it to death. 
It has been shown that the NO is involved in neuronal 
communication (Garthwaite 64) and possibly photoreceptor signaling 
(Stryer 116; Horio and Murad 3414). While in the brain nitric 
oxide can act either as a messenger or as a killer, depending on 
conditions. It has been shown that neurons containing NO synthase 
may actually kill their neighbors during a stroke. Nitric oxide 
synthase neurons typically are resistant to stroke damage but may 
in some cases become over stimulated by the excess 
neurotransmitters released during a stroke. Such excess floods 
nearby cells. This process causes nitric oxide to work as a killer 
to the body. 
Nitric oxide also sometimes does the work of a neurotransmitter but 
does not seem to act or look like any such messenger. A typical 
neurotransmitter is released from a storage area into the synapse 
when a neuron fires, but nitric oxide has no special storage 
facilities and no special release mechanism. NO seems to be made 
only when and where it is needed. When made, it simply diffuses 
out of the producing cell into where it is needed. Most 
neurotransmitters are composed of a string of peptides or amino 
acids which tend to couple with precisely configured receptors on 
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the surface of cells. When compared to this, nitric oxide is 
positively promiscuous. It needs no receptor gates because it 
simply passes through membranes like a ghost. Nitric oxide tends 
to target enzymes deep within cells, thus carrying its message to 
every cell in reach. 
One example of nitric oxide's importance to the body comes 
from sexual stimuli. Scientists have shown that in males nitric 
oxide translates sexual excitement into potency by causing 
erections (Culotta 1863). The brain sends messages to produce 
nitric oxide. When nitric oxide is released it dilates blood 
vessels throughout the crucial areas of the penis, blood rushes in, 
and the penis becomes erect. Laboratory studies on live rats 
proved that if NO synthesis is blocked, those all-important blood 
vessels would never dilate and thus the penis would stay limp 
(Culotta 1863). In addition to being found in the genitalia, 
nitric oxide also carries out functions as a neurotransmitter in 
the lungs and gut. During digestion, nitric oxide controls the 
contractions needed for digestion. When this process is blocked, 
as in some cases in infants, a potentially lethal condition called 
infantile hypertrophic pyloric stenosis develops. The lack of 
nitric oxide has been found to be the problem in this disorder. 
Nitric oxide may also help cells to store and retrieve 
information, which is the key to learning and memory. The basis 
for learning and remembering is thought to depend on strengthening 
the connection between sending and receiving neurons, the 
presynaptic and postsynaptic cells. A way to achieve this 
REFERENCE 
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strengthening is a process known as long term potentiation (LTP) in 
which repeated firing causes postsynaptic cells to respond more 
strongly the next time they receive a signal. One theory on how it 
works invokes a mysterious molecule that would travel backwards 
across the synapse and enhance the release of neurotransmitter in 
the presynaptic cell. Known as a "retrograde messenger" (Culotta 
1863), it would have to pass lightly from cell to cell without 
benefit of either release machinery or receptors, just like nitric 
oxide. Scientists have performed experiments in rats' hippocampal 
neurons. They found that LTP could be prevented by inhibiting 
nitric oxide synthesis. Scientists also injected NO inhibitors 
into the brains of live rats and found that the rats could no 
longer learn a water maze. One piece of the puzzle is missing 
before being able to crown NO as retrograde messenger. Thus far, 
no one has been able to detect nitric oxide synthase reliably in 
the hippocampal neurons that are supposed to be releasing nitric 
oxide. This research on hippocampal neurons will be important in 





The methodology for this study is based on techniques used by 
various researchers. These techniques for making porphyrin 
compounds have been proved time and time again to be successful; 
therefore, it was necessary to perfect these techniques before 
making the new porphyrin compound. This was accomplished by trying 
to replicate results from previous work done on a porphyrin 
compound. 
First, the known product of meso-tetraphenylporphyin was 
synthesized by reacting an equal molar quantity of benzaldehyde 
(F.W.= 106.12 g/mole) with pyrrole (F.W.=67.09 g/mole) in a large 
2-neck flask containing propionic acid (F.W.=74.08 g/mole). The 
benzaldehyde and pyrrole solution, which had a yellow color, turned 
to a dark brown color after its addition to propionic acid. The 
solution was then refluxed for thirty minutes and allowed to cool 
to room temperature. Cooling was aided by the use of a cold water 
bath. The solid product was then rinsed with methanol after being 
collected by filtration through a Buchner Funnel. Hot deionized 
water was then used to wash out the excess methanol. The purple 
filtrate collected was allowed to air dry by use of an aspirator. 
After the product dried, it was placed into a sample tube to be 
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used for the next reaction. 
The next step was to purify this tetraphenylporphyrin (TPP) 
product. This was done by adding the TPP to refluxing 
dichloromethane in a 2-neck round bottom boiling flask. A mixture 
of 2,3-dichloro-5,6 dycyanobenzoquinone (DGQ) and benzene was then 
added to the refluxing solution, using an addition funnel. The 
solution being added had a yellow color, while the solution being 
refluxed had a purple color. The color changed into a deep dark 
purple after being refluxed for thirty minutes. The solution was 
then rotovaped to dryness. A column was set up to perform column 
chromatography. A column of 500 ml was packed with cotton wool and 
Grade III Alumina in chloroform (CHC13). Extra chloroform was 
heated up for use as the eluent. Hot chloroform was then added to 
the rotovaped sample to dissolve it for the chromatographic 
procedure. The solution was poured slowly into the column. The 
solution was allowed to completely enter the column before the 
eluent was added. The eluent was slowly added until the product 
was separated in the column in a dark purple band. This band was 
collected in a large Erlenmeyer flask, transferred into a round 
bottom 1-neck flask, and rotovaped down to 100 ml. An equal amount 
of methanol was added to crystalize the product. This solution was 
left overnight in the refrigerator to increase crystallization. 
Next the purified crystals were filtered by running them through a 
glass sintered fritted funnel. The flask was rinsed with methanol 
and poured over the collected crystals. The purple crystals air 
dried through suction from an aspirator. The product was then 
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weighed and stored in a sample tube. A small quantity was used to 
run an infrared and ultraviolet spectra on the product to compare 
with literature values. 
The above reaction was performed three more times but was 
separated by different techniques. Instead of a column being used 
for the separation by chromatography, a glass sintered fritted 
funnel was used. This was packed only with grade III neutral 
alumina. The results achieved from this filtration were the same 
as for the column chromatographs, and the peaks from all of the 
reactions were similar to the literature values. Thus, the first 
technique for synthesizing an iron porphyrin compound was 
perfected. The technique used for the synthesis of the porphyrin 
compound was based on the work done by A.D Adler, F.R. Longo, and 
W. Shergalis, while the technique used for purification was based 
on work done by G.H. Barnett, M.F. Hudson, and K.M. Smith (1973). 
Next, this newly made porphyrin compound was used to synthesize the 
known tetraphenylporphineiron (III) chloride complex. This was 
done by reacting equal molar equivalents of the purified 
tetraphenylporphyrin to iron (II) chloride tetrahydrate in N, N-
Dimethylformamide in a 2-neck round bottom flask. The solution was 
then refluxed for five hours at 140°C. After refluxing was 
completed, the sample was rotovaped to dryness and the complex was 
dissolved in chloroform and a small volume of concentrated HCl. 
The solution was then rotovaped to dryness again. Chloroform was 
added to the complex again, but without concentrated HCl, and the 
complex was again separated by column chromatography. The packing 
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material was neutral Grade I Alumina and the eluent was chloroform. 
The second band was collected, which was the iron complex. The 
first band to come out of the column was the unreacted TPP. The 
sample collected had a dark brownish-purple color. The sample was 
then rotovaped to dryness. Xylene and hexane were added to 
dissolve the solid residue. The product was left overnight in the 
refrigerator to enable the complex to crystalize and to help 
increase the yield. Next, the solid obtained by suction filtration 
was collected. The dark purple crystals were rinsed with hexane 
and allowed to air dry. The filtrate containing the product was 
kept and left to crystalize for three days to get a better yield. 
After all the crystals were collected and dried, infrared and 
ultraviolet spectra were obtained for the product. This procedure 
was done three more times. The results seemed to stay consistent 
with the first reaction, and the peak for those reactions were 
compatible to the accepted peaks for the compound. This showed 
that the second step in synthesizing the iron porphyrin compound 
had been perfected. The technigue used for synthesizing the iron 
TPP chloride was based on work done by E.B. Fleischer, J.M. Palmer, 
A. Srivastava, and A. Chatterjee (1971). 
The next steps in the procedure involved the use of schlenk 
techniques, which required familiarity with the vacuum line. A 
synthesis reaction was performed with iron (TPP) chloride and 
silver triflate Ag(0S02CF3) to form Iron Triflate (TPP). Equal 
molar quantities were used of each compound and placed in a schlenk 
tube under a nitrogen atmosphere. Distilled THF was then added by 
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a gas tight syringe. The solution was heated for seven minutes, 
transferred into a three-neck round bottom flask by a transfer tube 
with filter paper attached to the end where the solution was in 
the schlenk tube. Distilled hexane was then added. After thirty 
minutes, the solution was filtered by transfer tube with filter 
paper attached. The liquid was discarded and the remaining 
precipitate washed with distilled Hexane, then filtered again. The 
product was dissolved with hot toluene and transferred into a two-
neck flask under nitrogen atmosphere. Hexane was added to the 
product solution and the solution was allowed to crystalize 
overnight. The product was then filtered by transfer tube and 
washed with distilled Hexane. The sample was vacuum-dried. 
Infrared and ultraviolet spectra were run on the product. The 
results of the spectra were similar to the literature values for 
that product; therefore, it was concluded that the first use of the 
vacuum line was a success. This technique was based on the work 
done by C.A. Reed and colleagues (1979). 
Using the vacuum line, synthesis of a sodium Iron 
tetraphenylporphyrin compound Na+(FeTPP)~ was begun by reacting one 
molar equivalents of Fe(TPP)Cl with two molar equivalents of either 
sodium anthracenide Na+ (CH H10)~ or sodium naphthalenide Na+( c10H8r. 
First the Fe(TPP)Cl was dissolved in distilled THF in a schlenk 
tube under a nitrogen atmosphere. The color of the solution was 
dark purple. In a separate schlenk tube, sodium and either 
anthracene or naphthalene were added to distilled THF. The color 
of the solution became green. Both schlenk tubes were stirred for 
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thirty minutes; then the solution with the sodium compound was 
added to the Fe(TPP)Cl solution. This was allowed to react for 
thirty minutes. Then the solution was filtered into a round bottom 
schlenk flask by transfer tube. Distilled hexane was then added to 
cause precipitation of the product. After crystallizing overnight, 
the product was transferred into a schlenk glass centered fritted 
funnel where it was filtered. The product was vacuumed dry and 
placed in a sample tube under a nitrogen atmosphere. Accepted 
peaks for the UV-vis bands were achieved, and it was concluded that 
the synthesis of the Na+(FeTPP)~ compound was a success. The color 
of the compound was purple. The procedure followed was 
established on the work done by T. Mashiko and colleagues (1984) and 
R.L. Letsinger and J.L. Finnan (1975). The next steps in 
synthesizing the nitric oxide iron porphyrin were reacting the 
Na+(FeTPP)~ and adding 4-Iodoanisole to distilled THF in a schlenk 
tube under a nitrogen atmosphere. This mixture was allowed to 
react for three hours. There seemed to be a color change from dark 
purple to a dark reddish-purple. The product then was taken to 
dryness. This procedure was based on the work done by D. Lexa, J. 
Mispelter, and J.M. Saveant(1981) . After this step, synthesizing 
of the new porphyrin compound was begun. 
The new compound was to be synthesized from 5-10, 15, 20-
Tetrakis (pentafluoro-phenyl)-21 H, 23 H-porphyrin iron III 
chloride (FeTPPFjCl). One molar equivalents of FeTPPF5Cl was 
reacted with two molar equivalents of Na+(C10Hg)~. The procedure was 
performed the same as in the reaction with Fe(TPP)Cl and Na+(C10Hg)~. 
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Infrared and ultraviolet spectra were taken and were compared to 
the infrared and ultraviolet spectra taken on the original sample 
to see if a reaction had occurred. The product of the reaction was 
then reacted with 4-Iodoanisole in distilled THF. Infrared and 
ultraviolet peaks were taken and compared to the original sample in 
the first reaction of the Fe(TPPF5)Cl with Na+(C10H8)~. 
This product was then reacted with nitric oxide. The 
technigue that was followed was established on the work of G. 
Lagrange and colleagues(1984). Infrared and ultraviolet spectra 
were run on the product. The infrared and ultraviolet spectra were 
run in a THF solvent. 
17 
Chapter IV 
Presentation of Findings 
Due to the expense of the starting material to be used for 
synthesizing, a study was performed with the use of TPP. After the 
TPP compound was synthesized an infrared and an ultraviolet 
spectra were obtained. The color of the product was sparkling 
purple. The yield for the synthesis of the product was twenty-four 
percent, while the yield for the product's purification was 
approximately eighty-eight percent. The infrared spectra was run 
in a KBr pellet and the ultraviolet spectra performed in a quartz 
cell using benzene as solvent. The results of the spectra were 
compared to accepted peaks for that compound (see Table 1 ). The 
accepted peaks for the infrared spectra were obtained from the 
spectra done by Udeni, a post-doc. in the lab, and the ultraviolet 
spectra were obtained from literature in the journal of Inoraanica 
Chemica Acta (1990). The actual spectra taken of the TPP compound 
are found in Tables 1.1 - 1.6. 
The next process in the trial procedures was to synthesize the 
Iron(III)(TPP) Chloride. This product's color was a dull purple. 
Infrared and an ultraviolet spectra were performed on the compound. 
The infrared spectra was run in a KBr pellet while the ultraviolet 
spectra was performed in a quartz cell with a solvent of benzene. 
The spectra were compared to accepted values for that compound. 
Table 2 compares the experimental values 
with the proved values. The actual spectra taken on the product 
can be found in Tables 2.1- 2.5. 




The synthesis of Iron (TPP) Triflate was very important 
because it is here that the schlenk techniques were introduced. 
These techniques were used for all the remaining reactions for the 
porphyrin compound. The product was a dark dull purple color and 
had a twenty-four percent yield. The infrared and ultraviolet 
spectra were compatible to the proven peak values for the compound. 
The infrared spectra were run in a standard KBr pellet, while the 
ultraviolet spectra were run in a quartz cell with a solvent of 
benzene. The experimental peaks are compared to the accepted peaks 
in Table 3. The true spectra taken are shown in Tables 3.1- 3.3. 
The formation of the Na+(FeTPP)~ was the next step in the 
process. The first reaction performed failed. The product formed 
was the oxo-dimer which occurs when the wanted product decomposes 
due to the presence of oxygen. The reducing agent used in the 
first reaction was anthracene. This reaction was repeated, but 
naphthalene was used as the reducing agent. The reaction was a 
success and was repeated to assure accuracy. The product formed 
had a dark brownish-purple color. The infrared and ultraviolet 
spectra were obtained from the second set of experimental data. 
These results were similar to the accepted spectra of that 
compound. The infrared spectra were performed under nitrogen in a 
KBr pellet and the ultraviolet spectra were run in a glass cell 
under nitrogen in a solvent of THF. A comparison of the 
experimental spectra with the accepted spectra of the compound is 
shown in Table 4. The genuine spectra taken of the compound can be 
found in Tables 4.1- 4.8. 
The newly made product Na+( TPPC10Hg)" was then reacted with an 
alkyl halide, 4-Iodoanisole. The color of the product changed from 
a dark brownish-purple to a dark brownish-red. This change in 
color could only be observed with the use of a flashlight. The 
product formed had a gummy crystalline nature quite different from 
the previous products, which had a solid crystalline nature. It 
was concluded that this was due to the excess of unreacted 
naphthalene or vacuum grease. 
Synthesis of the new porphyrin compound from the expensive 
starting sample of 5-10, 15, 20-Tetrakis (pentafluoro-phenyl)-21 H, 
23 H-porphine iron (III) chloride was then begun. The color of 
this starting sample was dark purple. Naphthalene was used as the 
reducing agent. Infrared and ultraviolet spectra were taken under 
nitrogen on the resulting product. The color of the resulting 
product was almost identical to that of the starting sample. These 
results were then compared to the peaks obtained from spectural 
analysis of the starting sample obtained from the Aldrich Chemical 
Company. The infrared spectra were performed in a KBr pellet and 
the ultraviolet spectra were performed in a glass cell in a 
solvent of THF. The comparison of peaks is shown in Table 5. The 
actual spectra performed on the product are shown in Tables 5.1-
5.5. The spectra of the aldrich starting sample can be seen in 
Table 5.6- 5.9. A grease infrared spectrum can also be found in 
Table 5.10. The grease spectrum is important in the elimination of 
grease peaks found in the products infrared spectra. 
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The newly formed product was then reacted with 4-Iodoanisole. 
The color changed from a dark purple to a dark brownish-purple. A 
spectural analysis was taken on the resulting product. The 
infrared and ultraviolet spectra were taken under nitrogen and then 
compared with the peaks obtained from the previous reaction. The 
infrared and ultraviolet spectra were taken in a solvent of THF. 
The ultraviolet spectra were taken in a glass cell. The second 
ultraviolet spectra taken were overlaid spectra which showed the 
compounds' tendency to decompose to the oxo-dimer. The spectural 
peaks obtained were compared in Table 6, while the actual spectra 
taken of the newly formed porphyrin compound are found in Tables 
6.1- 6.3. 
The newly formed porphyrin compound was then allowed to react 
with nitric oxide. The color slowly changed from a dark brownish-
purple to a dark brownish-green. This showed the product's 
susceptibility to decompose to the more stable oxo-dimer. 
Therefore an infrared and an ultraviolet spectra were performed 
immediately following the reaction of nitric oxide to the new 
porphyrin compound. The resulting porphyrin compound should be 
(TPP-F5)Fe(NO) (PhOMe) . This compound had a nitric oxide peak at 
1729.5 cm"1. This compound was then compared to (TPP-F5)Fe(NO)Ph, 
which was synthesized by another researcher in the laboratory, 
Douglas Pool. The nitric oxide peak obtained through the synthesis 
of his compound was 1712 cm-1. This comparison was then cross-
referenced to the difference in nitric oxide peaks in 
Fe(TPP) (C6H5) (NO) [NO peak at 1790 cm"1] and Fe(TPP) (p-OCH3C6H4) (NO) 
[NO peak at 1802 cm-1]. The difference in the peak value of the 
compound I synthesized with the compound Douglas synthesized was 
compatible with the difference found between the Fe(TPPF5 ) (C6H5) (NO) 
and the Fe(TPPF5 ) (p-OCH3C6HA) (NO) . An ultraviolet spectra was taken 
for additional data. This comparison and cross reference can be 
found in Table 7. The genuine spectra of the compound can be seen 
in Table 7.1-7.5. In conclusion, the product formed truly must be 
the (TPP-F5)Fe(NO) (PhOMe) porphyrin compound. 
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TABLE 1 
TPP TPP TPP TPP 
infrared infrared ultraviolet ultraviolet 
spectra spectra spectra spectra 









(Table 1.4) (Table 1.3) (Table 1.6) (p.20) 
1593.3 1595.9 646 648 
1555. 3 1558.4 592 592 
1470.3 1471.5 548 548 
1438.5 1441.5 514 515 
1347.3 1349.1 422 486 
1177.9 1178.5 414 419 
1071. 1 1072.4 374 -
979 .2 980. 1 296 -
964. 1 965.3 - -
755.9 758.4 - -
727 . 0 724.5 - -
697.8 698.9 - -
« n 3 B rfft-M.1 O) 3 O) T H X 23 
CO to CO CO CO o o 
00 OD CO CO O O 
• • • • • • • 
tn o cn o cn o cn 







o o o o 
H > 
DO r* m 

reo3aif+f+w. 3M3Q)T h  *e 



































JS 1.07W* u 
0.53023- . 
0.0000-





Reg A L 514 « 0.42731 
Reg A L 548 • 0.17552 
Reg A L 590 • 0.11859 
Reg A L 646 m 0.07481 
Reg A L 414 • 2.6888 m' 
Reg A L 412 m 2.6911 
Reg A L 422 m 2.5921 
Reg A L 374 • 0.54742 
Reg A L 296 m 0.28029 
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> WAVELENGTH SCAN REPORT < 

























Reg A L 646 
Reg A L 592 
Reg A L 548 
Reg A L 514 
Reg A L 422 
Reg A L 414 
Reg A L 374 










































(Table 2.1) (Table 2.2) Tab. 2.4-2.5 (p.16) 
1336 . 0 1336 .0 686 689 
1069.9 1070.7 572 572 
1001.9 1002.3 504 507 
798 . 4 801.7 414 418 
750.7 750.5 - 372 
699.8 700. 1 - -
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H > W r* 

/. yu 




















190 to 820 na 
1 a 
Off 
UBVgL  tMGTH 
Markad Wavalangths 
Rag A: L 572 - 1.0986 
Rag A: L 610 - 0.52061 
Rag A: L 690 - 0.24036 
Rag A: L 686 - 0.24301 
Rag A: L 656 - 0.24463 
> WAVELENGTH SCAN REPORT < 
























Reg A: L 572 - 1.6655 
Reg A: L 612 - 0.78572 
Reg A: L 656 « 0.22079 
Reg A: L 686 - 0.22047 
> WAVELENGTH SCAN REPORT < 























Reg A L 414 m  1.1484 
Reg A L 504 m  0.10660 
Reg A L 570 • 0.07292 
Reg A L 610 • 0.03664 
Reg A L 648 • 0.02258 
Reg A L 656 « 0.03459 
Reg A L 668 m  0.02200 
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TABLE 3 
Fe(0S02CF3) Fe(0S02CF3) Fe(0S02CF3) Fe(0S02CF3) 
TPP TPP TPP TPP 
infrared infrared ultraviolet ultraviolet 
spectra spectra spectra spectra 






(Table 3.1) (p.17) Tab.3.2-3.3) (p.17) 
1338.4 (s) 1340 (s) 664 656 
1231.1 (s) 1240 (s) 514 516 
1197.4 (s) 1205 (s) 410 412 
631.7 (s) 630 (s) - -
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a n  3  «  ft  f t  w  s u s s - } - i  
H > 
OB c-rr 
> WAVELENGTH SCAN REPORT < 























Reg A: L 514 - 1.7001 
Reg A: L 572 - 0.53206 
Reg A: L 606 - 0.34972 
Reg A: L 664 - 0.31445 
Reg A: L 684 - 0.31651 























Reg A: L 410 m  1.6889 
Reg A: L 510 m  0.12917 
Reg A: L 572 m  0.08849*^ 
Reg A: L 610 m  0. 04646*-. 
Reg A: L 510 « 0. 12917 S* 
Reg A: L 510 m  0.12917 
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TABLE 4 
Ma+(FeTPP)~ Ma+(FeTPP)~ Ha+(FeTPP)~ 
ultraviolet ultraviolet ultraviolet 
spectra spectra spectra 
experimental Reference Ref. Diner 
(THF) (THF) (THF) 
(Table 4.6) (p.18) (p.18) 
606 605 610 
572 575 570 
504 510 -
414 423 406 
372 390 318 

> WAVELENGTH SCAN REPORT < 
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> WAVELENGTH SCAN REPORT < 




















190 to 820 nm 
1 s 
Off 







R*g A: L 572 - 1.7425 
Reg A: L 652 - 1.2029 
Reg A: L 656 - 1.2414 
Reg A: L 686 - 1.2491 
> WAVELENGTH SCAN REPORT < 



























Rag A: L 506 - 1.4980 
Rag A: L 572 - 0.60275 
Rag A: L 650 « 0.40063 
Rag A: L 656 - 0.43507 
Rag A: L 686 - 0.41470 
> WAVELENGTH SCAN REPORT < 
Lla Nam* : 























Rag A: L 312 - 1.1624 
Rag A: L 414 » 2.5443 
Rag A: L 504 - 0.32559 
Rag A: L §2.2 « 0.17082 
f Rag A: L 606 * 0.12064 
> WAVELENGTH SCAN REPORT < 
























Rag A: L 374 - 0.67445 
Rag A: L 416 - 1.5809 
Rag A: L 486 - 0.19038 
Rag A: L 502 - 0.19739 
Rag A: L 572 - 0.11623 

























4oo no «» *» 
Marked Wavelengths 
Rag A: L 416 - 1.0618 
Rag A: L 486 - 0.15843 
Rag A: L 502 - 0.14963 
Rag A: L 572 - 0.10304 
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TABLE 5 
*«+(FeTPPF5 ) FeCl (TPPF5) •a+(FeTPPF5 ) FeCl(TPPF5 ) 
Infrared Infrared ultraviolet ultraviolet 
spectra spectra spectra spectra 
experimental Ref.Aldrlch experimental Ref.Aldrlch 
(KBr) (KBr) (THF) (THF) 
^-1 ^-1 nm nm 
(Table 5.1) (Table 5.6) Tab.5.2, 5.4 Tab.5.7, 5.8 
1713.3 - 622 620 
1604.0 - 564 562 
1260.6 - 560 -
1092.3 1080.3 496 496 
1022.0 - 444 -
990.7 988.9 416 412 
938.5 938.8 406 348 
798.1 805.8 348 -
759 .5 759.6 324 -
474 .4 - - -
























Reg A: L 348 - 2.5398 
Reg A: L 416 - 3.4243 
Reg A: L 496 - 0.67766 
Reg A: L 562 - 0.47176 
Reg A: L 622 - 0.35963 
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Reg A: L 560 - 0.16327 
Reg A: L 408 - 0.90643 




















190 to 820 nm 
1 s 
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Marked Wavelengths 
Reg A: L 560 - 0.12750 
Reg A: L 564 « 0. 12750 
Reg A: L 444 - 0.46120 
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> WAVELENGTH SCAN REPORT < 


















190 to 820 nm 
1 s 
Off 
H > 09 f PI 
Marked Wavelengths 
Reg A: L 496 « 0.97131 
Reg A: L 562 - 0.63351 
Reg A: L 620 - 0.50247 
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Reg A: L 348 - 1.1051 
Reg A: L 412 - 2.3121 
Reg A: L 494 - 0.33554 
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> WAVELENGTH SCAN REPORT < 













Function : Absorbance 
Wavelength Range : 190 to 820 nm 
Integration Time : 1 s 
Std Deviation : Off 
H > 
CD r* m 
Marked Wavelengths 
Reg A: L 350 - 0.72900 
Reg A: L 412 « 1.5427 
Reg A: L 560 - 0.21123 

















cn , o H 
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(TPP-F5)Fe (TPP-F5)FeCl (TPP-F5)Fe ( TPP-F5 ) FeCl 
(PhOMe) infrared (PhOMe) ultraviolet 
infrared spectra ultraviolet spectra 
spectra Ref. spectra Ref. 
experimental Aldrich experimental Aldrich 
(THF) (THF) (THF) (THF) 
^-1 cm-1 nm nm 
(Table 6.1) (Table 5.6) (Table 6.3) (Table 5.9) 
2034 .2 - 562 560 
1779 .4 - 448 -
1645.6 1649.9 412 412 
1598.4 - - -
1524.2 - - -
790.8 - - -
760.3 759 . 6 - -
586.6 - - -
60 
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> WAVELENGTH SCAN REPORT < 

























Reg A: L 446 - 2.4986 
Reg A: L 562 « 0.69234 
—> Overlaid Spectra < 
eg File Name Sample Name 
I T>fF  
G 1.£>CC?> 
Marked Wavelengths 
Reg F: L 448 « 0.92900x 
Reg B: L 412 - 1.9041 " 
Reg G: L 562 « 0.24434 
Reg G: L 562 « 0.24434 
Reg G: L 562 - 0.24434 ̂  
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TABLE 7 
(TPP-F5) (TPP-F5) Fe(TPP) Fe(TPP) 
Fe(MO) Fe(HO)Ph (C^) (MO) (EOCH3C6H/,) 
(PhOMe) infrared infrared (MO) 
infrared spectra spectra infrared 
spectra experimental (cross Ref.) spectra 
experimental (cross Ref.) (cross Ref) 
(THF) (THF) (THF) (THF) 
^-1 cm-1 cm"1 
(Table 7.1) (Table 7.2) (p.19) (p.19) 
1729.5 1712 .8 1790 1802 
in 3 on h 64 
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Reg A: L 500 - 0.59326 
Reg A: L 622 - 0.33653 
Reg A: L 406 - 3.4421 
Reg A: L 348 - 2.3341 
Reg A: L 294 - 1.7587 
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Marked Wavelengths 
Reg A: L 292 - 1.0451 
Reg A: L 348 - 1.1019 
Reg A: L 410 - 2.4583 
Reg A: L 500 » 0.27116 
Marked Wavelengths 
Reg A: L 560 - 0.10950 
Reg A: L 442 * 0.40169 
Reg A: L 410 - 0.75696 
Reg A: L 336 » 0.29767 
Reg A: L 292 « 0.57578 
69 
Chapter V 
Summary and Conclusion 
As stated by Daniel E. Koshland Jr. in the December 18,1992, 
edition of Science Magazine, nitric oxide plays a variety of roles 
in the body. It helps in the maintenance of blood pressure by 
dilating blood vessels, it helps the immune response by aiding in 
the killing of foreign invaders, it has proven to be a major 
biochemical mediator of penile erections, and it is probably one of 
the most important biochemical components of long term memory. By 
getting a better understanding of nitric oxide's chemistry one can 
possibly help design drugs that could turn the production of nitric 
oxide on and off. By understanding this chemistry one can possibly 
prevent many diseases caused by nitric oxide. Among these are 
septic shock and hypertension. 
In brief, nitric oxide's unpaired electron allows the molecule 
to have high reactivity and metal-binding properties which enable 
it to destroy the metabolic machinery of a cell. This reactivity 
also contributes to its lability and limits the molecule's effects 
to the circumscribed area of its release. The most common use of 
nitric oxide is in nitroglycerin. Jack R. Lancaster, Jr., has 
summed up nitric oxide's importance to the medical society. In the 
May-June 1992 edition of American Scientist he states that "the 
story of nitric oxide provides an example of the increasing utility 
of chemistry in solving the problems of medical science." 
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